Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEVOFLOXACIN vs LEVOSIMENDAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEVOFLOXACIN vs LEVOSIMENDAN: Safety Overview

Metric LEVOFLOXACIN LEVOSIMENDAN
Total FAERS Reports 40,403 183
Deaths Reported 2,747 37
Death Rate 6.8% 20.2%
Hospitalizations 13,832 103
Average Patient Age 59.4 yrs 49.9 yrs
% Female Patients 54.7% 42.5%
FDA Approval Date Apr 22, 2020 N/A
Manufacturer BPI LABS LLC N/A
Route OPHTHALMIC N/A
Marketing Status Discontinued N/A